Sources | Names Used |
---|---|
CTRPv2 | PRL-3 inhibitor I |
PharmacoGx | PRL-3 Inhibitor I |
Database | Identifier |
---|---|
Smiles: | Brc1ccc(OCc2ccccc2Br)c(/C=C3/SC(=S)NC3=O)c1 |
Pubchem: | 11983303 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | EDA | CTRPv2 | pan-cancer | AAC | 0.076 | 0.06 |
mRNA | RP11-565P22.6 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.06 |
mRNA | GS1-393G12.13 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.06 |
mRNA | PSORS1C1 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.06 |
mRNA | PTGFRN | CTRPv2 | pan-cancer | AAC | -0.086 | 0.06 |
mRNA | ERVFRD-1 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.06 |
mRNA | KIR3DX1 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.06 |
mRNA | MAGEB16 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.06 |
mRNA | SMIM18 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.06 |
mRNA | GJD2 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |